Dabo Health Names Robert V. Stanek CEO and Expands National

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Dabo Health Names Robert V. Stanek CEO and Expands National Presence

PHILADELPHIA and SAN FRANCISCO, Dec. 17, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Dabo Health today announced that Robert V. Stanek is the company's new Chief Executive Officer, succeeding Camilo Barcenas who will now serve as Founder and Chief Development Officer. In addition, the company is establishing an East Coast office in Philadelphia, Pa., with the design and engineering team remaining in San Francisco, Calif.

"The Dabo platform is built around the needs of the healthcare provider," said Mr. Barcenas. "We have had tremendous success to date--engaging 300+ hospitals throughout the United States. I couldn't be more excited to work with Bob to further Dabo Health's mission and facilitate local, regional, and national performance improvement by delivering simplified, actionable data to frontline care providers."

Dabo Health is an innovative platform that uses a social media format to provide easy access to information and metrics that helps nurses, physicians, and front line staff have the information needed to improve quality of care. Dabo Health is currently completing a pilot project at Mayo Clinic . By providing healthcare providers with simple, streamlined and readily accessible information, Dabo Health provides care givers with a broad scope of quality data and networking opportunities to facilitate collaboration, adopt best practices, and ultimately improve quality of care. This improved quality will facilitate hospital compliance and maximize reimbursement in keeping with requirements of the Affordable Care Act.

"Dabo Health has developed a highly innovative and differentiated online and mobile visualization platform for providers and payers to make key performance metrics accessible and actionable, while identifying best practices to improve care quality and reduce costs," said Mr. Stanek. "In my experience, when you empower the hands-on healthcare provider--a physician or a nurse--you have the opportunity to derive the best possible outcome for the patient. Dabo Health was founded by a visionary whose background has been predicated around improving patient care by implementing innovation solutions. I look forward to building on my many years of service within the healthcare community, and to introducing this innovative platform to hospitals, health systems and payors to help them implement a system that will ensure the best quality of care for their patients."

Mr. Stanek has more than 35 years of experience working with multi-hospital systems and corporate organizations. Prior to Dabo Health, Mr. Stanek served as president and chief executive officer of Catholic Health East ("CHE"). During his tenure, CHE included 34 acute care hospitals, four long-term acute care hospitals, 25 freestanding and hospital-based long-term care facilities, 14 assisted-living facilities, four continuing care retirement communities, eight behavioral health and rehabilitation facilities, 37 home health and hospice agencies, and numerous ambulatory and community-based health services. CHE facilities employed approximately 54,000 full-time employees. Stanek joined CHE's Senior Management Team in 1997 and was promoted in 2003 to become the health system's second president and chief executive officer.

Prior to joining CHE, Mr. Stanek served in a variety of capacities with the Mercy Health System of Western New York, including president and chief executive officer. He also served as chief executive officer of Mercy Hospital in Buffalo. Before 1992, Stanek served in a number of administrative positions with the Daughters of Charity healthcare facilities in Pennsylvania & Virginia.

Stanek was elected to the board of trustees of the Catholic Health Association of the United States (CHAUSA) in 2006. Comprised of more than 600 hospitals and 1,400 long-term care and other health facilities in all 50 states, CHAUSA is the largest group of nonprofit health care providers in the nation. Stanek has served as Chairperson-elect from June 2009 through June 2010, and Chairperson from June 2011 through June 2012. He served as the Speaker of the Assembly from June 2012 through June 2013.

Mr. Stanek currently serves on the Board of Directors of Accumen, a hospital laboratory management company, as well as chairs its Audit Committee. In addition, he was a founding board member of Seamless Health, an Accretive Company. He also serves on the Board of Accretive Health, a publically traded entity, providing hospital billing services.

Mr. Stanek earned a bachelor of arts degree in chemistry from East Stroudsburg University in East Stroudsburg, Pa.; a B.S. in pharmacy from the Philadelphia College of Pharmacy and Science; and an M.B.A. in administrative management from St. Joseph's University, Philadelphia, Pa.

About Dabo Health

Dabo Health, Inc. provides the healthcare community with an online visualization platform to view and track improvement in key performance metrics, collaborate across hospitals and healthcare systems, and identify and share learnings to save lives--providing a solution that enables providers and payers to improve patient care, reduce per capita cost and maximize reimbursements. Founded in 2011, Dabo Health has raised funding provided by institutional and strategic investors including aeris Capital , Albany Holdings and Safeguard Scientifics (NYSE: SFE ). For more information about Dabo Health or to launch a pilot program in your hospital, please visit http://www.dabohealth.com .

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/12/prweb12400018.htm

Dabo Health, Inc. Heather Hunter +1 2155312225

Scroll down for more posts ▼

Top 10 Most Recent News Articles

M&A Source's 2026 Conference Tackles Deal-Making Drama

Updated Category News Views 130

High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...

Continue Reading
Endava Faces Class Action: Investors Eye Their Next Move

Updated Category News Views 0

A Mess That Investors Can't Ignore If you're holding onto Endava plc shares, you've probably felt that gut-punch lately. Yeah, things are getting heated with a class action lawsuit alleging the company played fast and loose with its accounting practices. The complaint's about some shady dealings that may have thrown off investors' perceptions. The Core Allegations This...

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 36

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
OneQode & AdaniConneX Forge AI Path in India

Updated Category News Views 17

A Major Step Forward in AI Infrastructure When two heavyweights clash, you better believe folks are paying attention. OneQode’s deal with AdaniConneX is like a shot across the bow in the AI infrastructure arena. They’re not just dipping a toe in India’s tech waters; they’re diving headfirst with 14 MW of data center muscle right there in Siruseri Sipcot, Chennai....

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 48

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Brightstar's Cash Pop Shakes Up Illinois Lottery Scene

Updated Category News Views 63

A New Twist in Illinois: Cash Pop's Arrival Here's something fresh off the press: the Illinois Lottery is now on the ride with Brightstar's Cash Pop. This patented game isn't just another number pick—it's an engaging draw-based game featuring hourly draws with price tags of $1, $2, $5, and $10. It's like clockwork, and trust me, it's more than just the usual spin....

Continue Reading
Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 91

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
Amgen Declares Q4 Dividend Amidst Broad Horizons

Updated Category News Views 16

Amgen's Steady Dividend: A Testament to Stability Diving into the mess that is today's biotech market, Amgen (NASDAQ:AMGN) stands out like a beacon of stability with its recent dividend announcement. The Board's decision to dole out a $2.52 per share dividend for the fourth quarter of 2026 showcases confidence amidst both promising ventures and looming uncertainties....

Continue Reading
2026 World Laureates Forum Drives Science Forward

Updated Category News Views 78

A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...

Continue Reading
Mercado González Opens, Integrates Mexican Culture

Updated Category News Views 27

Dive into Mercado González's Cultural Opening Over in La Habra, Northgate González Market has just flung open the doors to its latest masterpiece: Mercado González. Picture this, a place where the mundanity of grocery shopping melds with a vibrant fiesta of Mexican cuisine, artisanry, and cultural vibes. They transformed an older store into something that commands not...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Exelon's Earnings: Insights and Future Potential

Updated Category News Views 142

Understanding Exelon's Upcoming Earnings Report Exelon Corporation (NASDAQ: EXC) is preparing to reveal its quarterly earnings in the near future. Investors are keenly awaiting the results, as they want insights into the company’s performance and projections for the following period. Analysts predict that Exelon will report an earnings per share (EPS) of $0.39,...

Continue Reading
Vallourec Invites Warrant Holders to General Meeting

Updated Category News Views 157

Vallourec Invites Warrant Holders to General Meeting Vallourec has announced a significant upcoming event for its warrant holders, also known as BSA. This meeting is set to take place soon, providing an opportunity for holders to engage with the company's future decisions. Details of the Meeting The general meeting will occur at the Vallourec headquarters, where the...

Continue Reading
Investigation Initiated for Molina Healthcare Investors Following Financial Reports

Updated Category News Views 246

Pomerantz LLP Begins Investigation on Behalf of Molina Investors Pomerantz LLP has embarked on an investigation focusing on the interests of investors in Molina Healthcare, Inc. (NYSE: MOH). This inquiry aims to ascertain whether Molina and certain executives may have been involved in any unlawful activities related to securities fraud. Key Financial Findings and Investor...

Continue Reading
How SymphonyAI's Insights Drive E-commerce Growth in Grocery

Updated Category News Views 159

Unlocking E-commerce Potential in Grocery Retail In a transformative announcement, SymphonyAI, a leader in predictive and generative AI SaaS products for enterprises, has unveiled groundbreaking insights from its annual grocery e-commerce study. This research indicates a noteworthy 8% growth opportunity for retailers leveraging AI-driven strategies in their connected...

Continue Reading
Exploring the Impact of Honda and Nissan's Potential Merger

Updated Category News Views 408

Honda and Nissan's Strategic Talks Honda (NYSE:HMC) and Nissan (OTC:NSANY) have entered discussions that may lead to a potential merger, a significant move reflecting the shifting landscape of Japan's automotive industry. As these two giants explore deeper ties, it marks a notable strategy to face the competition posed by Tesla and various Chinese car manufacturers....

Continue Reading